+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Peptide Therapeutics Market by Product Type (Antimicrobial Peptides, Cell Penetrating Peptides, Peptide Hormones), Synthesis Technique (Recombinant Peptides, Synthetic Peptides), Route Of Administration, Application, End User - Global Forecast 2025-2030- Product Image
Peptide Therapeutics Market by Product Type (Antimicrobial Peptides, Cell Penetrating Peptides, Peptide Hormones), Synthesis Technique (Recombinant Peptides, Synthetic Peptides), Route Of Administration, Application, End User - Global Forecast 2025-2030- Product Image
Sale

Peptide Therapeutics Market by Product Type (Antimicrobial Peptides, Cell Penetrating Peptides, Peptide Hormones), Synthesis Technique (Recombinant Peptides, Synthetic Peptides), Route Of Administration, Application, End User - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 193 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 4968565
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The peptide therapeutics market is rapidly advancing as scientific innovation, evolving patient demands, and changing regulatory landscapes converge, prompting organizations to refine development and commercialization strategies.

Market Snapshot: Peptide Therapeutics Industry Outlook

The Peptide Therapeutics Market grew from USD 35.76 billion in 2024 to USD 38.88 billion in 2025. It is expected to continue growing at a CAGR of 8.39%, reaching USD 58.02 billion by 2030.

This expansion reflects increased adoption of peptides in diverse therapy areas, supported by new manufacturing methods and therapeutic delivery technologies. Senior decision-makers benefit from understanding this market’s scale and direction, as global trends and investment priorities shape future growth trajectories.

Scope & Segmentation

This report delivers a comprehensive segmentation of the peptide therapeutics landscape, with in-depth coverage across products, production methods, applications, and geographic regions:

  • Product Types: Antimicrobial peptides, cell penetrating peptides, peptide hormones, peptide vaccines
  • Synthesis Techniques: Recombinant peptides, synthetic peptides
  • Routes of Administration: Inhalation, injectable (intramuscular, intravenous, subcutaneous), oral (capsule, liquid, tablet), topical, transdermal
  • Application Areas: Cardiovascular diseases (heart failure, hypertension), infectious diseases (hepatitis, HIV, influenza), metabolic disorders (diabetes, obesity), oncology (breast cancer, lung cancer, melanoma)
  • End Users: Clinics, hospitals, research institutes
  • Geographies Covered: Americas (United States, Canada, Mexico, Brazil, Argentina), Europe, Middle East & Africa (including United Kingdom, Germany, France, Russia, and others), Asia-Pacific (China, India, Japan, Australia, South Korea, and more)
  • Key Companies Covered: Novo Nordisk A/S, Eli Lilly and Company, Sanofi S.A., Ferring Pharmaceuticals A/S, Merck & Co., Inc., Pfizer Inc., Novartis International AG, Takeda Pharmaceutical Company Limited, Amgen Inc., Ipsen S.A.

This structure equips stakeholders with a detailed view of competitive positioning and market access opportunities, supporting informed decision making in both established and emerging segments.

Key Takeaways: Strategic Insights for Peptide Therapeutics Stakeholders

  • Recent technological progress in molecular design and manufacturing has facilitated the development of peptide drugs with improved yield, purity, and target precision.
  • Refined computational modeling and high-throughput screening are enabling faster identification of novel candidates, optimizing clinical trial timelines and success rates.
  • Adaptive regulatory pathways help accelerate the clinical evaluation of peptide-based therapies, with authorities worldwide updating approval frameworks to suit innovative drug modalities.
  • Oral and non-injectable delivery platforms are emerging, expanding market reach and potentially improving patient compliance, especially for chronic therapies.
  • Collaborations between large pharmaceutical companies, specialized biotechs, and contract manufacturing organizations drive innovation and diversify clinical pipelines.
  • Real-world evidence strategies, including digital health integration, are enhancing post-market surveillance, supporting value-based care, and strengthening reimbursement cases.

Tariff Impact: Navigating Regulatory Compliance and Supply Chain Risks

Recent tariff measures in the United States have influenced supply chain operations and increased input costs. These changes prompt companies to reassess sourcing strategies, adapt to new vendor landscapes, and adjust production footprints. Large organizations are reevaluating supplier networks, while smaller manufacturers face greater price and compliance pressures. Strategies such as vertical integration, collaboration with domestic producers, and adoption of advanced manufacturing help to mitigate these risks and protect margins.

Methodology & Data Sources

This report is built on a blend of primary and secondary research. It draws from desk research, literature reviews, regulatory resources, and industry publications, complemented by interviews with industry experts. Triangulation and peer review processes ensure data integrity and actionable findings.

Why This Report Matters for Decision-Makers

  • Delivers segmented insights to identify emerging investment and partnership opportunities within the peptide therapeutics sector.
  • Provides an evidence-based foundation for evaluating technology trends, regulatory shifts, and supply chain dynamics.
  • Supports development of region- and segment-specific market entry or expansion strategies aligned with evolving healthcare needs.

Conclusion

The peptide therapeutics market is evolving amid rapid scientific advances and regulatory changes. Organizations that align innovation, operational resilience, and digital health capabilities are best positioned for sustainable success in this dynamic landscape.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Advancements in oral peptide delivery technologies enhancing patient compliance and market penetration
5.2. Integration of peptide-based immunotherapies with checkpoint inhibitors to improve cancer treatment efficacy
5.3. Emergence of automated peptide synthesizer platforms reducing production costs and boosting scalability in R&D
5.4. Growing adoption of bioactive peptide nutraceuticals for preventive healthcare and wellness market expansion
5.5. Market entry of long-acting peptide analogues transforming diabetes management and patient quality of life outcomes
5.6. Advances in non-invasive peptide diagnostic assays enabling early disease detection and real-time biomarker monitoring
5.7. Strategic partnerships between biotech firms and CMOs to accelerate peptide therapeutic manufacturing and commercialization
5.8. Regulatory guidances evolving to address peptide biosimilars and facilitate market access of interchangeable products
5.9. Adoption of AI-driven sequence optimization platforms to design potent and stable peptide drug candidates more efficiently
5.10. Investment surge in peptide vaccine development for infectious diseases driven by mRNA-peptide hybrid platform innovations
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Peptide Therapeutics Market, by Product Type
8.1. Introduction
8.2. Antimicrobial Peptides
8.3. Cell Penetrating Peptides
8.4. Peptide Hormones
8.5. Peptide Vaccines
9. Peptide Therapeutics Market, by Synthesis Technique
9.1. Introduction
9.2. Recombinant Peptides
9.3. Synthetic Peptides
10. Peptide Therapeutics Market, by Route Of Administration
10.1. Introduction
10.2. Inhalation
10.3. Injectable
10.3.1. Intramuscular
10.3.2. Intravenous
10.3.3. Subcutaneous
10.4. Oral
10.4.1. Capsule
10.4.2. Liquid
10.4.3. Tablet
10.5. Topical
10.6. Transdermal
11. Peptide Therapeutics Market, by Application
11.1. Introduction
11.2. Cardiovascular Diseases
11.2.1. Heart Failure
11.2.2. Hypertension
11.3. Infectious Diseases
11.3.1. Hepatitis
11.3.2. Hiv
11.3.3. Influenza
11.4. Metabolic Disorders
11.4.1. Diabetes
11.4.2. Obesity
11.5. Oncology
11.5.1. Breast Cancer
11.5.2. Lung Cancer
11.5.3. Melanoma
12. Peptide Therapeutics Market, by End User
12.1. Introduction
12.2. Clinics
12.3. Hospitals
12.4. Research Institutes
13. Americas Peptide Therapeutics Market
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
14. Europe, Middle East & Africa Peptide Therapeutics Market
14.1. Introduction
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
15. Asia-Pacific Peptide Therapeutics Market
15.1. Introduction
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. Novo Nordisk A/S
16.3.2. Eli Lilly and Company
16.3.3. Sanofi S.A.
16.3.4. Ferring Pharmaceuticals A/S
16.3.5. Merck & Co., Inc.
16.3.6. Pfizer Inc.
16.3.7. Novartis International AG
16.3.8. Takeda Pharmaceutical Company Limited
16.3.9. Amgen Inc.
16.3.10. Ipsen S.A.
17. ResearchAI
18. ResearchStatistics
19. ResearchContacts
20. ResearchArticles
21. Appendix
List of Figures
FIGURE 1. PEPTIDE THERAPEUTICS MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL PEPTIDE THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL PEPTIDE THERAPEUTICS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL PEPTIDE THERAPEUTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL PEPTIDE THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 6. GLOBAL PEPTIDE THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL PEPTIDE THERAPEUTICS MARKET SIZE, BY SYNTHESIS TECHNIQUE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL PEPTIDE THERAPEUTICS MARKET SIZE, BY SYNTHESIS TECHNIQUE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL PEPTIDE THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2030 (%)
FIGURE 10. GLOBAL PEPTIDE THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL PEPTIDE THERAPEUTICS MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 12. GLOBAL PEPTIDE THERAPEUTICS MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL PEPTIDE THERAPEUTICS MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 14. GLOBAL PEPTIDE THERAPEUTICS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS PEPTIDE THERAPEUTICS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS PEPTIDE THERAPEUTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES PEPTIDE THERAPEUTICS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES PEPTIDE THERAPEUTICS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA PEPTIDE THERAPEUTICS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA PEPTIDE THERAPEUTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC PEPTIDE THERAPEUTICS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC PEPTIDE THERAPEUTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. PEPTIDE THERAPEUTICS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. PEPTIDE THERAPEUTICS MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 25. PEPTIDE THERAPEUTICS MARKET: RESEARCHAI
FIGURE 26. PEPTIDE THERAPEUTICS MARKET: RESEARCHSTATISTICS
FIGURE 27. PEPTIDE THERAPEUTICS MARKET: RESEARCHCONTACTS
FIGURE 28. PEPTIDE THERAPEUTICS MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. PEPTIDE THERAPEUTICS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL PEPTIDE THERAPEUTICS MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL PEPTIDE THERAPEUTICS MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL PEPTIDE THERAPEUTICS MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL PEPTIDE THERAPEUTICS MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL PEPTIDE THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL PEPTIDE THERAPEUTICS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL PEPTIDE THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL PEPTIDE THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL PEPTIDE THERAPEUTICS MARKET SIZE, BY ANTIMICROBIAL PEPTIDES, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL PEPTIDE THERAPEUTICS MARKET SIZE, BY ANTIMICROBIAL PEPTIDES, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL PEPTIDE THERAPEUTICS MARKET SIZE, BY CELL PENETRATING PEPTIDES, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL PEPTIDE THERAPEUTICS MARKET SIZE, BY CELL PENETRATING PEPTIDES, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL PEPTIDE THERAPEUTICS MARKET SIZE, BY PEPTIDE HORMONES, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL PEPTIDE THERAPEUTICS MARKET SIZE, BY PEPTIDE HORMONES, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL PEPTIDE THERAPEUTICS MARKET SIZE, BY PEPTIDE VACCINES, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL PEPTIDE THERAPEUTICS MARKET SIZE, BY PEPTIDE VACCINES, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL PEPTIDE THERAPEUTICS MARKET SIZE, BY SYNTHESIS TECHNIQUE, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL PEPTIDE THERAPEUTICS MARKET SIZE, BY SYNTHESIS TECHNIQUE, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL PEPTIDE THERAPEUTICS MARKET SIZE, BY RECOMBINANT PEPTIDES, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL PEPTIDE THERAPEUTICS MARKET SIZE, BY RECOMBINANT PEPTIDES, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL PEPTIDE THERAPEUTICS MARKET SIZE, BY SYNTHETIC PEPTIDES, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL PEPTIDE THERAPEUTICS MARKET SIZE, BY SYNTHETIC PEPTIDES, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL PEPTIDE THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL PEPTIDE THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL PEPTIDE THERAPEUTICS MARKET SIZE, BY INHALATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL PEPTIDE THERAPEUTICS MARKET SIZE, BY INHALATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL PEPTIDE THERAPEUTICS MARKET SIZE, BY INJECTABLE, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL PEPTIDE THERAPEUTICS MARKET SIZE, BY INJECTABLE, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL PEPTIDE THERAPEUTICS MARKET SIZE, BY INTRAMUSCULAR, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL PEPTIDE THERAPEUTICS MARKET SIZE, BY INTRAMUSCULAR, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL PEPTIDE THERAPEUTICS MARKET SIZE, BY INTRAVENOUS, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL PEPTIDE THERAPEUTICS MARKET SIZE, BY INTRAVENOUS, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL PEPTIDE THERAPEUTICS MARKET SIZE, BY SUBCUTANEOUS, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL PEPTIDE THERAPEUTICS MARKET SIZE, BY SUBCUTANEOUS, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL PEPTIDE THERAPEUTICS MARKET SIZE, BY INJECTABLE, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL PEPTIDE THERAPEUTICS MARKET SIZE, BY INJECTABLE, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL PEPTIDE THERAPEUTICS MARKET SIZE, BY ORAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL PEPTIDE THERAPEUTICS MARKET SIZE, BY ORAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL PEPTIDE THERAPEUTICS MARKET SIZE, BY CAPSULE, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL PEPTIDE THERAPEUTICS MARKET SIZE, BY CAPSULE, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL PEPTIDE THERAPEUTICS MARKET SIZE, BY LIQUID, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL PEPTIDE THERAPEUTICS MARKET SIZE, BY LIQUID, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL PEPTIDE THERAPEUTICS MARKET SIZE, BY TABLET, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL PEPTIDE THERAPEUTICS MARKET SIZE, BY TABLET, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL PEPTIDE THERAPEUTICS MARKET SIZE, BY ORAL, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL PEPTIDE THERAPEUTICS MARKET SIZE, BY ORAL, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL PEPTIDE THERAPEUTICS MARKET SIZE, BY TOPICAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL PEPTIDE THERAPEUTICS MARKET SIZE, BY TOPICAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL PEPTIDE THERAPEUTICS MARKET SIZE, BY TRANSDERMAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL PEPTIDE THERAPEUTICS MARKET SIZE, BY TRANSDERMAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL PEPTIDE THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL PEPTIDE THERAPEUTICS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL PEPTIDE THERAPEUTICS MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL PEPTIDE THERAPEUTICS MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL PEPTIDE THERAPEUTICS MARKET SIZE, BY HEART FAILURE, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL PEPTIDE THERAPEUTICS MARKET SIZE, BY HEART FAILURE, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL PEPTIDE THERAPEUTICS MARKET SIZE, BY HYPERTENSION, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL PEPTIDE THERAPEUTICS MARKET SIZE, BY HYPERTENSION, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL PEPTIDE THERAPEUTICS MARKET SIZE, BY CARDIOVASCULAR DISEASES, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL PEPTIDE THERAPEUTICS MARKET SIZE, BY CARDIOVASCULAR DISEASES, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL PEPTIDE THERAPEUTICS MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL PEPTIDE THERAPEUTICS MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL PEPTIDE THERAPEUTICS MARKET SIZE, BY HEPATITIS, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL PEPTIDE THERAPEUTICS MARKET SIZE, BY HEPATITIS, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL PEPTIDE THERAPEUTICS MARKET SIZE, BY HIV, BY REGION, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL PEPTIDE THERAPEUTICS MARKET SIZE, BY HIV, BY REGION, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL PEPTIDE THERAPEUTICS MARKET SIZE, BY INFLUENZA, BY REGION, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL PEPTIDE THERAPEUTICS MARKET SIZE, BY INFLUENZA, BY REGION, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL PEPTIDE THERAPEUTICS MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL PEPTIDE THERAPEUTICS MARKET SIZE, BY INFECTIOUS DISEASES, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL PEPTIDE THERAPEUTICS MARKET SIZE, BY METABOLIC DISORDERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL PEPTIDE THERAPEUTICS MARKET SIZE, BY METABOLIC DISORDERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL PEPTIDE THERAPEUTICS MARKET SIZE, BY DIABETES, BY REGION, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL PEPTIDE THERAPEUTICS MARKET SIZE, BY DIABETES, BY REGION, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL PEPTIDE THERAPEUTICS MARKET SIZE, BY OBESITY, BY REGION, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL PEPTIDE THERAPEUTICS MARKET SIZE, BY OBESITY, BY REGION, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL PEPTIDE THERAPEUTICS MARKET SIZE, BY METABOLIC DISORDERS, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL PEPTIDE THERAPEUTICS MARKET SIZE, BY METABOLIC DISORDERS, 2025-2030 (USD MILLION)
TABLE 81. GLOBAL PEPTIDE THERAPEUTICS MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2024 (USD MILLION)
TABLE 82. GLOBAL PEPTIDE THERAPEUTICS MARKET SIZE, BY ONCOLOGY, BY REGION, 2025-2030 (USD MILLION)
TABLE 83. GLOBAL PEPTIDE THERAPEUTICS MARKET SIZE, BY BREAST CANCER, BY REGION, 2018-2024 (USD MILLION)
TABLE 84. GLOBAL PEPTIDE THERAPEUTICS MARKET SIZE, BY BREAST CANCER, BY REGION, 2025-2030 (USD MILLION)
TABLE 85. GLOBAL PEPTIDE THERAPEUTICS MARKET SIZE, BY LUNG CANCER, BY REGION, 2018-2024 (USD MILLION)
TABLE 86. GLOBAL PEPTIDE THERAPEUTICS MARKET SIZE, BY LUNG CANCER, BY REGION, 2025-2030 (USD MILLION)
TABLE 87. GLOBAL PEPTIDE THERAPEUTICS MARKET SIZE, BY MELANOMA, BY REGION, 2018-2024 (USD MILLION)
TABLE 88. GLOBAL PEPTIDE THERAPEUTICS MARKET SIZE, BY MELANOMA, BY REGION, 2025-2030 (USD MILLION)
TABLE 89. GLOBAL PEPTIDE THERAPEUTICS MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 90. GLOBAL PEPTIDE THERAPEUTICS MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 91. GLOBAL PEPTIDE THERAPEUTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 92. GLOBAL PEPTIDE THERAPEUTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 93. GLOBAL PEPTIDE THERAPEUTICS MARKET SIZE, BY CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 94. GLOBAL PEPTIDE THERAPEUTICS MARKET SIZE, BY CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 95. GLOBAL PEPTIDE THERAPEUTICS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 96. GLOBAL PEPTIDE THERAPEUTICS MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 97. GLOBAL PEPTIDE THERAPEUTICS MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2024 (USD MILLION)
TABLE 98. GLOBAL PEPTIDE THERAPEUTICS MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2025-2030 (USD MILLION)
TABLE 99. AMERICAS PEPTIDE THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 100. AMERICAS PEPTIDE THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 101. AMERICAS PEPTIDE THERAPEUTICS MARKET SIZE, BY SYNTHESIS TECHNIQUE, 2018-2024 (USD MILLION)
TABLE 102. AMERICAS PEPTIDE THERAPEUTICS MARKET SIZE, BY SYNTHESIS TECHNIQUE, 2025-2030 (USD MILLION)
TABLE 103. AMERICAS PEPTIDE THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 104. AMERICAS PEPTIDE THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 105. AMERICAS PEPTIDE THERAPEUTICS MARKET SIZE, BY INJECTABLE, 2018-2024 (USD MILLION)
TABLE 106. AMERICAS PEPTIDE THERAPEUTICS MARKET SIZE, BY INJECTABLE, 2025-2030 (USD MILLION)
TABLE 107. AMERICAS PEPTIDE THERAPEUTICS MARKET SIZE, BY ORAL, 2018-2024 (USD MILLION)
TABLE 108. AMERICAS PEPTIDE THERAPEUTICS MARKET SIZE, BY ORAL, 2025-2030 (USD MILLION)
TABLE 109. AMERICAS PEPTIDE THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 110. AMERICAS PEPTIDE THERAPEUTICS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 111. AMERICAS PEPTIDE THERAPEUTICS MARKET SIZE, BY CARDIOVASCULAR DISEASES, 2018-2024 (USD MILLION)
TABLE 112. AMERICAS PEPTIDE THERAPEUTICS MARKET SIZE, BY CARDIOVASCULAR DISEASES, 2025-2030 (USD MILLION)
TABLE 113. AMERICAS PEPTIDE THERAPEUTICS MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2024 (USD MILLION)
TABLE 114. AMERICAS PEPTIDE THERAPEUTICS MARKET SIZE, BY INFECTIOUS DISEASES, 2025-2030 (USD MILLION)
TABLE 115. AMERICAS PEPTIDE THERAPEUTICS MARKET SIZE, BY METABOLIC DISORDERS, 2018-2024 (USD MILLION)
TABLE 116. AMERICAS PEPTIDE THERAPEUTICS MARKET SIZE, BY METABOLIC DISORDERS, 2025-2030 (USD MILLION)
TABLE 117. AMERICAS PEPTIDE THERAPEUTICS MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 118. AMERICAS PEPTIDE THERAPEUTICS MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 119. AMERICAS PEPTIDE THERAPEUTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 120. AMERICAS PEPTIDE THERAPEUTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 121. AMERICAS PEPTIDE THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 122. AMERICAS PEPTIDE THERAPEUTICS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 123. UNITED STATES PEPTIDE THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 124. UNITED STATES PEPTIDE THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 125. UNITED STATES PEPTIDE THERAPEUTICS MARKET SIZE, BY SYNTHESIS TECHNIQUE, 2018-2024 (USD MILLION)
TABLE 126. UNITED STATES PEPTIDE THERAPEUTICS MARKET SIZE, BY SYNTHESIS TECHNIQUE, 2025-2030 (USD MILLION)
TABLE 127. UNITED STATES PEPTIDE THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 128. UNITED STATES PEPTIDE THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 129. UNITED STATES PEPTIDE THERAPEUTICS MARKET SIZE, BY INJECTABLE, 2018-2024 (USD MILLION)
TABLE 130. UNITED STATES PEPTIDE THERAPEUTICS MARKET SIZE, BY INJECTABLE, 2025-2030 (USD MILLION)
TABLE 131. UNITED STATES PEPTIDE THERAPEUTICS MARKET SIZE, BY ORAL, 2018-2024 (USD MILLION)
TABLE 132. UNITED STATES PEPTIDE THERAPEUTICS MARKET SIZE, BY ORAL, 2025-2030 (USD MILLION)
TABLE 133. UNITED STATES PEPTIDE THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 134. UNITED STATES PEPTIDE THERAPEUTICS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 135. UNITED STATES PEPTIDE THERAPEUTICS MARKET SIZE, BY CARDIOVASCULAR DISEASES, 2018-2024 (USD MILLION)
TABLE 136. UNITED STATES PEPTIDE THERAPEUTICS MARKET SIZE, BY CARDIOVASCULAR DISEASES, 2025-2030 (USD MILLION)
TABLE 137. UNITED STATES PEPTIDE THERAPEUTICS MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2024 (USD MILLION)
TABLE 138. UNITED STATES PEPTIDE THERAPEUTICS MARKET SIZE, BY INFECTIOUS DISEASES, 2025-2030 (USD MILLION)
TABLE 139. UNITED STATES PEPTIDE THERAPEUTICS MARKET SIZE, BY METABOLIC DISORDERS, 2018-2024 (USD MILLION)
TABLE 140. UNITED STATES PEPTIDE THERAPEUTICS MARKET SIZE, BY METABOLIC DISORDERS, 2025-2030 (USD MILLION)
TABLE 141. UNITED STATES PEPTIDE THERAPEUTICS MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 142. UNITED STATES PEPTIDE THERAPEUTICS MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 143. UNITED STATES PEPTIDE THERAPEUTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 144. UNITED STATES PEPTIDE THERAPEUTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 145. UNITED STATES PEPTIDE THERAPEUTICS MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 146. UNITED STATES PEPTIDE THERAPEUTICS MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 147. CANADA PEPTIDE THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 148. CANADA PEPTIDE THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 149. CANADA PEPTIDE THERAPEUTICS MARKET SIZE, BY SYNTHESIS TECHNIQUE, 2018-2024 (USD MILLION)
TABLE 150. CANADA PEPTIDE THERAPEUTICS MARKET SIZE, BY SYNTHESIS TECHNIQUE, 2025-2030 (USD MILLION)
TABLE 151. CANADA PEPTIDE THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 152. CANADA PEPTIDE THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 153. CANADA PEPTIDE THERAPEUTICS MARKET SIZE, BY INJECTABLE, 2018-2024 (USD MILLION)
TABLE 154. CANADA PEPTIDE THERAPEUTICS MARKET SIZE, BY INJECTABLE, 2025-2030 (USD MILLION)
TABLE 155. CANADA PEPTIDE THERAPEUTICS MARKET SIZE, BY ORAL, 2018-2024 (USD MILLION)
TABLE 156. CANADA PEPTIDE THERAPEUTICS MARKET SIZE, BY ORAL, 2025-2030 (USD MILLION)
TABLE 157. CANADA PEPTIDE THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 158. CANADA PEPTIDE THERAPEUTICS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 159. CANADA PEPTIDE THERAPEUTICS MARKET SIZE, BY CARDIOVASCULAR DISEASES, 2018-2024 (USD MILLION)
TABLE 160. CANADA PEPTIDE THERAPEUTICS MARKET SIZE, BY CARDIOVASCULAR DISEASES, 2025-2030 (USD MILLION)
TABLE 161. CANADA PEPTIDE THERAPEUTICS MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2024 (USD MILLION)
TABLE 162. CANADA PEPTIDE THERAPEUTICS MARKET SIZE, BY INFECTIOUS DISEASES, 2025-2030 (USD MILLION)
TABLE 163. CANADA PEPTIDE THERAPEUTICS MARKET SIZE, BY METABOLIC DISORDERS, 2018-2024 (USD MILLION)
TABLE 164. CANADA PEPTIDE THERAPEUTICS MARKET SIZE, BY METABOLIC DISORDERS, 2025-2030 (USD MILLION)
TABLE 165. CANADA PEPTIDE THERAPEUTICS MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 166. CANADA PEPTIDE THERAPEUTICS MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 167. CANADA PEPTIDE THERAPEUTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 168. CANADA PEPTIDE THERAPEUTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 169. MEXICO PEPTIDE THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 170. MEXICO PEPTIDE THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 171. MEXICO PEPTIDE THERAPEUTICS MARKET SIZE, BY SYNTHESIS TECHNIQUE, 2018-2024 (USD MILLION)
TABLE 172. MEXICO PEPTIDE THERAPEUTICS MARKET SIZE, BY SYNTHESIS TECHNIQUE, 2025-2030 (USD MILLION)
TABLE 173. MEXICO PEPTIDE THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 174. MEXICO PEPTIDE THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 175. MEXICO PEPTIDE THERAPEUTICS MARKET SIZE, BY INJECTABLE, 2018-2024 (USD MILLION)
TABLE 176. MEXICO PEPTIDE THERAPEUTICS MARKET SIZE, BY INJECTABLE, 2025-2030 (USD MILLION)
TABLE 177. MEXICO PEPTIDE THERAPEUTICS MARKET SIZE, BY ORAL, 2018-2024 (USD MILLION)
TABLE 178. MEXICO PEPTIDE THERAPEUTICS MARKET SIZE, BY ORAL, 2025-2030 (USD MILLION)
TABLE 179. MEXICO PEPTIDE THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 180. MEXICO PEPTIDE THERAPEUTICS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 181. MEXICO PEPTIDE THERAPEUTICS MARKET SIZE, BY CARDIOVASCULAR DISEASES, 2018-2024 (USD MILLION)
TABLE 182. MEXICO PEPTIDE THERAPEUTICS MARKET SIZE, BY CARDIOVASCULAR DISEASES, 2025-2030 (USD MILLION)
TABLE 183. MEXICO PEPTIDE THERAPEUTICS MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2024 (USD MILLION)
TABLE 184. MEXICO PEPTIDE THERAPEUTICS MARKET SIZE, BY INFECTIOUS DISEASES, 2025-2030 (USD MILLION)
TABLE 185. MEXICO PEPTIDE THERAPEUTICS MARKET SIZE, BY METABOLIC DISORDERS, 2018-2024 (USD MILLION)
TABLE 186. MEXICO PEPTIDE THERAPEUTICS MARKET SIZE, BY METABOLIC DISORDERS, 2025-2030 (USD MILLION)
TABLE 187. MEXICO PEPTIDE THERAPEUTICS MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 188. MEXICO PEPTIDE THERAPEUTICS MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 189. MEXICO PEPTIDE THERAPEUTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 190. MEXICO PEPTIDE THERAPEUTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 191. BRAZIL PEPTIDE THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 192. BRAZIL PEPTIDE THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 193. BRAZIL PEPTIDE THERAPEUTICS MARKET SIZE, BY SYNTHESIS TECHNIQUE, 2018-2024 (USD MILLION)
TABLE 194. BRAZIL PEPTIDE THERAPEUTICS MARKET SIZE, BY SYNTHESIS TECHNIQUE, 2025-2030 (USD MILLION)
TABLE 195. BRAZIL PEPTIDE THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 196. BRAZIL PEPTIDE THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 197. BRAZIL PEPTIDE THERAPEUTICS MARKET SIZE, BY INJECTABLE, 2018-2024 (USD MILLION)
TABLE 198. BRAZIL PEPTIDE THERAPEUTICS MARKET SIZE, BY INJECTABLE, 2025-2030 (USD MILLION)
TABLE 199. BRAZIL PEPTIDE THERAPEUTICS MARKET SIZE, BY ORAL, 2018-2024 (USD MILLION)
TABLE 200. BRAZIL PEPTIDE THERAPEUTICS MARKET SIZE, BY ORAL, 2025-2030 (USD MILLION)
TABLE 201. BRAZIL PEPTIDE THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 202. BRAZIL PEPTIDE THERAPEUTICS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 203. BRAZIL PEPTIDE THERAPEUTICS MARKET SIZE, BY CARDIOVASCULAR DISEASES, 2018-2024 (USD MILLION)
TABLE 204. BRAZIL PEPTIDE THERAPEUTICS MARKET SIZE, BY CARDIOVASCULAR DISEASES, 2025-2030 (USD MILLION)
TABLE 205. BRAZIL PEPTIDE THERAPEUTICS MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2024 (USD MILLION)
TABLE 206. BRAZIL PEPTIDE THERAPEUTICS MARKET SIZE, BY INFECTIOUS DISEASES, 2025-2030 (USD MILLION)
TABLE 207. BRAZIL PEPTIDE THERAPEUTICS MARKET SIZE, BY METABOLIC DISORDERS, 2018-2024 (USD MILLION)
TABLE 208. BRAZIL PEPTIDE THERAPEUTICS MARKET SIZE, BY METABOLIC DISORDERS, 2025-2030 (USD MILLION)
TABLE 209. BRAZIL PEPTIDE THERAPEUTICS MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 210. BRAZIL PEPTIDE THERAPEUTICS MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 211. BRAZIL PEPTIDE THERAPEUTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 212. BRAZIL PEPTIDE THERAPEUTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 213. ARGENTINA PEPTIDE THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 214. ARGENTINA PEPTIDE THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 215. ARGENTINA PEPTIDE THERAPEUTICS MARKET SIZE, BY SYNTHESIS TECHNIQUE, 2018-2024 (USD MILLION)
TABLE 216. ARGENTINA PEPTIDE THERAPEUTICS MARKET SIZE, BY SYNTHESIS TECHNIQUE, 2025-2030 (USD MILLION)
TABLE 217. ARGENTINA PEPTIDE THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 218. ARGENTINA PEPTIDE THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 219. ARGENTINA PEPTIDE THERAPEUTICS MARKET SIZE, BY INJECTABLE, 2018-2024 (USD MILLION)
TABLE 220. ARGENTINA PEPTIDE THERAPEUTICS MARKET SIZE, BY INJECTABLE, 2025-2030 (USD MILLION)
TABLE 221. ARGENTINA PEPTIDE THERAPEUTICS MARKET SIZE, BY ORAL, 2018-2024 (USD MILLION)
TABLE 222. ARGENTINA PEPTIDE THERAPEUTICS MARKET SIZE, BY ORAL, 2025-2030 (USD MILLION)
TABLE 223. ARGENTINA PEPTIDE THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 224. ARGENTINA PEPTIDE THERAPEUTICS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 225. ARGENTINA PEPTIDE THERAPEUTICS MARKET SIZE, BY CARDIOVASCULAR DISEASES, 2018-2024 (USD MILLION)
TABLE 226. ARGENTINA PEPTIDE THERAPEUTICS MARKET SIZE, BY CARDIOVASCULAR DISEASES, 2025-2030 (USD MILLION)
TABLE 227. ARGENTINA PEPTIDE THERAPEUTICS MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2024 (USD MILLION)
TABLE 228. ARGENTINA PEPTIDE THERAPEUTICS MARKET SIZE, BY INFECTIOUS DISEASES, 2025-2030 (USD MILLION)
TABLE 229. ARGENTINA PEPTIDE THERAPEUTICS MARKET SIZE, BY METABOLIC DISORDERS, 2018-2024 (USD MILLION)
TABLE 230. ARGENTINA PEPTIDE THERAPEUTICS MARKET SIZE, BY METABOLIC DISORDERS, 2025-2030 (USD MILLION)
TABLE 231. ARGENTINA PEPTIDE THERAPEUTICS MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 232. ARGENTINA PEPTIDE THERAPEUTICS MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 233. ARGENTINA PEPTIDE THERAPEUTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 234. ARGENTINA PEPTIDE THERAPEUTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 235. EUROPE, MIDDLE EAST & AFRICA PEPTIDE THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 236. EUROPE, MIDDLE EAST & AFRICA PEPTIDE THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 237. EUROPE, MIDDLE EAST & AFRICA PEPTIDE THERAPEUTICS MARKET SIZE, BY SYNTHESIS TECHNIQUE, 2018-2024 (USD MILLION)
TABLE 238. EUROPE, MIDDLE EAST & AFRICA PEPTIDE THERAPEUTICS MARKET SIZE, BY SYNTHESIS TECHNIQUE, 2025-2030 (USD MILLION)
TABLE 239. EUROPE, MIDDLE EAST & AFRICA PEPTIDE THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 240. EUROPE, MIDDLE EAST & AFRICA PEPTIDE THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 241. EUROPE, MIDDLE EAST & AFRICA PEPTIDE THERAPEUTICS MARKET SIZE, BY INJECTABLE, 2018-2024 (USD MILLION)
TABLE 242. EUROPE, MIDDLE EAST & AFRICA PEPTIDE THERAPEUTICS MARKET SIZE, BY INJECTABLE, 2025-2030 (USD MILLION)
TABLE 243. EUROPE, MIDDLE EAST & AFRICA PEPTIDE THERAPEUTICS MARKET SIZE, BY ORAL, 2018-2024 (USD MILLION)
TABLE 244. EUROPE, MIDDLE EAST & AFRICA PEPTIDE THERAPEUTICS MARKET SIZE, BY ORAL, 2025-2030 (USD MILLION)
TABLE 245. EUROPE, MIDDLE EAST & AFRICA PEPTIDE THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 246. EUROPE, MIDDLE EAST & AFRICA PEPTIDE THERAPEUTICS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 247. EUROPE, MIDDLE EAST & AFRICA PEPTIDE THERAPEUTICS MARKET SIZE, BY CARDIOVASCULAR DISEASES, 2018-2024 (USD MILLION)
TABLE 248. EUROPE, MIDDLE EAST & AFRICA PEPTIDE THERAPEUTICS MARKET SIZE, BY CARDIOVASCULAR DISEASES, 2025-2030 (USD MILLION)
TABLE 249. EUROPE, MIDDLE EAST & AFRICA PEPTIDE THERAPEUTICS MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2024 (USD MILLION)
TABLE 250. EUROPE, MIDDLE EAST & AFRICA PEPTIDE THERAPEUTICS MARKET SIZE, BY INFECTIOUS DISEASES, 2025-2030 (USD MILLION)
TABLE 251. EUROPE, MIDDLE EAST & AFRICA PEPTIDE THERAPEUTICS MARKET SIZE, BY METABOLIC DISORDERS, 2018-2024 (USD MILLION)
TABLE 252. EUROPE, MIDDLE EAST & AFRICA PEPTIDE THERAPEUTICS MARKET SIZE, BY METABOLIC DISORDERS, 2025-2030 (USD MILLION)
TABLE 253. EUROPE, MIDDLE EAST & AFRICA PEPTIDE THERAPEUTICS MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 254. EUROPE, MIDDLE EAST & AFRICA PEPTIDE THERAPEUTICS MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 255. EUROPE, MIDDLE EAST & AFRICA PEPTIDE THERAPEUTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 256. EUROPE, MIDDLE EAST & AFRICA PEPTIDE THERAPEUTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 257. EUROPE, MIDDLE EAST & AFRICA PEPTIDE THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 258. EUROPE, MIDDLE EAST & AFRICA PEPTIDE THERAPEUTICS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 259. UNITED KINGDOM PEPTIDE THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 260. UNITED KINGDOM PEPTIDE THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 261. UNITED KINGDOM PEPTIDE THERAPEUTICS MARKET SIZE, BY SYNTHESIS TECHNIQUE, 2018-2024 (USD MILLION)
TABLE 262. UNITED KINGDOM PEPTIDE THERAPEUTICS MARKET SIZE, BY SYNTHESIS TECHNIQUE, 2025-2030 (USD MILLION)
TABLE 263. UNITED KINGDOM PEPTIDE THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 264. UNITED KINGDOM PEPTIDE THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 265. UNITED KINGDOM PEPTIDE THERAPEUTICS MARKET SIZE, BY INJECTABLE, 2018-2024 (USD MILLION)
TABLE 266. UNITED KINGDOM PEPTIDE THERAPEUTICS MARKET SIZE, BY INJECTABLE, 2025-2030 (USD MILLION)
TABLE 267. UNITED KINGDOM PEPTIDE THERAPEUTICS MARKET SIZE, BY ORAL, 2018-2024 (USD MILLION)
TABLE 268. UNITED KINGDOM PEPTIDE THERAPEUTICS MARKET SIZE, BY ORAL, 2025-2030 (USD MILLION)
TABLE 269. UNITED KINGDOM PEPTIDE THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 270. UNITED KINGDOM PEPTIDE THERAPEUTICS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 271. UNITED KINGDOM PEPTIDE THERAPEUTICS MARKET SIZE, BY CARDIOVASCULAR DISEASES, 2018-2024 (USD MILLION)
TABLE 272. UNITED KINGDOM PEPTIDE THERAPEUTICS MARKET SIZE, BY CARDIOVASCULAR DISEASES, 2025-2030 (USD MILLION)
TABLE 273. UNITED KINGDOM PEPTIDE THERAPEUTICS MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2024 (USD MILLION)
TABLE 274. UNITED KINGDOM PEPTIDE THERAPEUTICS MARKET SIZE, BY INFECTIOUS DISEASES, 2025-2030 (USD MILLION)
TABLE 275. UNITED KINGDOM PEPTIDE THERAPEUTICS MARKET SIZE, BY METABOLIC DISORDERS, 2018-2024 (USD MILLION)
TABLE 276. UNITED KINGDOM PEPTIDE THERAPEUTICS MARKET SIZE, BY METABOLIC DISORDERS, 2025-2030 (USD MILLION)
TABLE 277. UNITED KINGDOM PEPTIDE THERAPEUTICS MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 278. UNITED KINGDOM PEPTIDE THERAPEUTICS MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 279. UNITED KINGDOM PEPTIDE THERAPEUTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 280. UNITED KINGDOM PEPTIDE THERAPEUTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 281. GERMANY PEPTIDE THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 282. GERMANY PEPTIDE THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 283. GERMANY PEPTIDE THERAPEUTICS MARKET SIZE, BY SYNTHESIS TECHNIQUE, 2018-2024 (USD MILLION)
TABLE 284. GERMANY PEPTIDE THERAPEUTICS MARKET SIZE, BY SYNTHESIS TECHNIQUE, 2025-2030 (USD MILLION)
TABLE 285. GERMANY PEPTIDE THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 286. GERMANY PEPTIDE THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 287. GERMANY PEPTIDE THERAPEUTICS MARKET SIZE, BY INJECTABLE, 2018-2024 (USD MILLION)
TABLE 288. GERMANY PEPTIDE THERAPEUTICS MARKET SIZE, BY INJECTABLE, 2025-2030 (USD MILLION)
TABLE 289. GERMANY PEPTIDE THERAPEUTICS MARKET SIZE, BY ORAL, 2018-2024 (USD MILLION)
TABLE 290. GERMANY PEPTIDE THERAPEUTICS MARKET SIZE, BY ORAL, 2025-2030 (USD MILLION)
TABLE 291. GERMANY PEPTIDE THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 292. GERMANY PEPTIDE THERAPEUTICS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 293. GERMANY PEPTIDE THERAPEUTICS MARKET SIZE, BY CARDIOVASCULAR DISEASES, 2018-2024 (USD MILLION)
TABLE 294. GERMANY PEPTIDE THERAPEUTICS MARKET SIZE, BY CARDIOVASCULAR DISEASES, 2025-2030 (USD MILLION)
TABLE 295. GERMANY PEPTIDE THERAPEUTICS MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2024 (USD MILLION)
TABLE 296. GERMANY PEPTIDE THERAPEUTICS MARKET SIZE, BY INFECTIOUS DISEASES, 2025-2030 (USD MILLION)
TABLE 297. GERMANY PEPTIDE THERAPEUTICS MARKET SIZE, BY METABOLIC DISORDERS, 2018-2024 (USD MILLION)
TABLE 298. GERMANY PEPTIDE THERAPEUTICS MARKET SIZE, BY METABOLIC DISORDERS, 2025-2030 (USD MILLION)
TABLE 299. GERMANY PEPTIDE THERAPEUTICS MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 300. GERMANY PEPTIDE THERAPEUTICS MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 301. GERMANY PEPTIDE THERAPEUTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 302. GERMANY PEPTIDE THERAPEUTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 303. FRANCE PEPTIDE THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 304. FRANCE PEPTIDE THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 305. FRANCE PEPTIDE THERAPEUTICS MARKET SIZE, BY SYNTHESIS TECHNIQUE, 2018-2024 (USD MILLION)
TABLE 306. FRANCE PEPTIDE THERAPEUTICS MARKET SIZE, BY SYNTHESIS TECHNIQUE, 2025-2030 (USD MILLION)
TABLE 307. FRANCE PEPTIDE THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 308. FRANCE PEPTIDE THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 309. FRANCE PEPTIDE THERAPEUTICS MARKET SIZE, BY INJECTABLE, 2018-2024 (USD MILLION)
TABLE 310. FRANCE PEPTIDE THERAPEUTICS MARKET SIZE, BY INJECTABLE, 2025-2030 (USD MILLION)
TABLE 311. FRANCE PEPTIDE THERAPEUTICS MARKET SIZE, BY ORAL, 2018-2024 (USD MILLION)
TABLE 312. FRANCE PEPTIDE THERAPEUTICS MARKET SIZE, BY ORAL, 2025-2030 (USD MILLION)
TABLE 313. FRANCE PEPTIDE THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 314. FRANCE PEPTIDE THERAPEUTICS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 315. FRANCE PEPTIDE THERAPEUTICS MARKET SIZE, BY CARDIOVASCULAR DISEASES, 2018-2024 (USD MILLION)
TABLE 316. FRANCE PEPTIDE THERAPEUTICS MARKET SIZE, BY CARDIOVASCULAR DISEASES, 2025-2030 (USD MILLION)
TABLE 317. FRANCE PEPTIDE THERAPEUTICS MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2024 (USD MILLION)
TABLE 318. FRANCE PEPTIDE THERAPEUTICS MARKET SIZE, BY INFECTIOUS DISEASES, 2025-2030 (USD MILLION)
TABLE 319. FRANCE PEPTIDE THERAPEUTICS MARKET SIZE, BY METABOLIC DISORDERS, 2018-2024 (USD MILLION)
TABLE 320. FRANCE PEPTIDE THERAPEUTICS MARKET SIZE, BY METABOLIC DISORDERS, 2025-2030 (USD MILLION)
TABLE 321. FRANCE PEPTIDE THERAPEUTICS MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 322. FRANCE PEPTIDE THERAPEUTICS MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 323. FRANCE PEPTIDE THERAPEUTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 324. FRANCE PEPTIDE THERAPEUTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 325. RUSSIA PEPTIDE THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 326. RUSSIA PEPTIDE THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 327. RUSSIA PEPTIDE THERAPEUTICS MARKET SIZE, BY SYNTHESIS TECHNIQUE, 2018-2024 (USD MILLION)
TABLE 328. RUSSIA PEPTIDE THERAPEUTICS MARKET SIZE, BY SYNTHESIS TECHNIQUE, 2025-2030 (USD MILLION)
TABLE 329. RUSSIA PEPTIDE THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 330. RUSSIA PEPTIDE THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 331. RU

Samples

Loading
LOADING...

Companies Mentioned

  • Novo Nordisk A/S
  • Eli Lilly and Company
  • Sanofi S.A.
  • Ferring Pharmaceuticals A/S
  • Merck & Co., Inc.
  • Pfizer Inc.
  • Novartis International AG
  • Takeda Pharmaceutical Company Limited
  • Amgen Inc.
  • Ipsen S.A.

Table Information

Report AttributeDetails
No. of Pages193
PublishedAugust 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 38.88 Billion
Forecasted Market Value ( USD ) by 2030 $ 58.02 Billion
Compound Annual Growth Rate8.3%
Regions CoveredGlobal
No. of Companies Mentioned10

Related Topics

Related Reports

Peptide Therapeutics Market Size, Share & Trends Analysis Report by Application, Type (Innovative, Generic), Type of Manufacturer (Inhouse, Outsourced), Route of Administration, Synthesis Technology, and Region with Growth Forecasts, 2025-2030 - Product Image

Peptide Therapeutics Market Size, Share & Trends Analysis Report by Application, Type (Innovative, Generic), Type of Manufacturer (Inhouse, Outsourced), Route of Administration, Synthesis Technology, and Region with Growth Forecasts, 2025-2030

  • Report
  • 153 Pages
  • Global
From
Peptide Therapeutics - Global Strategic Business Report - Product Image

Peptide Therapeutics - Global Strategic Business Report

  • Report
  • 192 Pages
  • Global
From
Peptide Therapeutics Market Report 2025 - Product Image

Peptide Therapeutics Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Peptide Therapeutics Market Report: Trends, Forecast and Competitive Analysis to 2031 - Product Image

Peptide Therapeutics Market Report: Trends, Forecast and Competitive Analysis to 2031

  • Report
  • 150 Pages
  • Global
From
Peptide Therapeutics Market Report by Type, Type of Manufacturer, Synthesis Technology, Routes of Administration, Application, and Region 2024-2032 - Product Image

Peptide Therapeutics Market Report by Type, Type of Manufacturer, Synthesis Technology, Routes of Administration, Application, and Region 2024-2032

  • Report
  • 138 Pages
  • Global
From

About the Peptide Therapeutic Market

The Peptide Therapeutic market is a subset of the Proteomics industry, which focuses on the study of proteins and their functions. Peptide Therapeutics are a type of drug that are composed of short chains of amino acids, and are used to treat a variety of diseases. These drugs are typically used to target specific proteins in the body, and can be used to treat conditions such as cancer, diabetes, and autoimmune diseases. Peptide Therapeutics are often used in combination with other drugs, such as chemotherapy, to maximize their effectiveness. The Peptide Therapeutic market is highly competitive, with many companies developing and marketing these drugs. Some of the major players in the market include Amgen, Merck, Novartis, Pfizer, and Sanofi. Other companies such as AbbVie, AstraZeneca, and Eli Lilly are also active in the market. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.